Serum METRNL Concentration in Type 2 Diabetes

N/ACompletedNCT03194100

Chungnam National University Hospital125 enrolled

Overview

The investigators measured serum METRNL levels in newly diagnosed patients with type 2 diabetes (T2DM) compared with normal glucose tolerance or prediabetes and explored the correlations between its serum levels and various metabolic parameters

Study Type

OBSERVATIONAL

Enrollment

125

Conditions

Diabetes Mellitus, Type 2

Eligibility

Sex: ALLMin age: 19 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who have not been diagnosed diabetes mellitus Exclusion Criteria: * Person with diabetes who were treated with oral hypoglycemic agent or insulin * Individuals with type 1 diabetes, gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure, or other known major disease

Outcomes

Primary Outcomes

serum METRNL concentration

Time frame: on the 1 day of oral glucose tolerance test

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.